Suvretta Capital Management »

Arcus Biosciences Incorporated shares owned by Suvretta Capital Management

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Suvretta Capital Management from 13F filings

Historical chart of Suvretta Capital Management investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Suvretta Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Suvretta Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $15M 957k 15.23
2024-03-31 $18M 957k 18.88
2023-09-30 $11M 597k 17.95

More positions owned by Suvretta Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Biohaven (BHVN)
Insmed Com Par $.01 (INSM)
Kura Oncology (KURA)
Intra Cellular Therapies (ITCI)
Arcutis Biotherapeutics (ARQT)
Ultragenyx Pharmaceutical (RARE)
Meta Platforms Cl A (META)
Arcellx Common Stock (ACLX)
UnitedHealth (UNH)
Apple (AAPL)
Amazon (AMZN)
89bio (ETNB)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Advanced Micro Devices (AMD)

View all positions for Suvretta Capital Management

Top funds holding Arcus Biosciences Incorporated

BlackRock
BlackRock
Vanguard Group
Woodline Partners
State Street Corporation
Point72 Asset Management
Siren
Invus Financial Advisors
Boxer Capital
Dimensional Fund Advisors
Alliancebernstein
Geode Capital Management
Suvretta Capital Management
Bnp Paribas Investment Partners
Decheng Capital

View all funds holding Arcus Biosciences Incorporated